Sign in Pull a receipt

TVGN

Tevogen Inc.

Healthcare · Biotechnology

$202.76 sample

+1.31 (+0.65%) 1D

Market cap

$797.2B

Price as of

2026-10-29

Latest filing

8-K · 2026-09-23

Alerts

8

Price$202.76 +1.36% 3M daily closessample

218.25192.42

2026-08-032026-08-252026-09-162026-10-072026-10-29

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 27INSInsider sell: 10% owner
Oct 19INSInsider sell: Chief Executive Officer
Oct 08INSInsider sell: 10% owner
Oct 05INSInsider sell: Chief Executive Officer
Sep 28INSInsider sell: EVP, Operations
Sep 23SECDEF 14A filed
Sep 18INSInsider buy: General Counsel
Sep 10INSInsider sell: Chief Financial Officer

Sign up to see the real TVGN record →

Company facts

SEC EDGAR registration

Name: Tevogen Inc.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: +11sample, -100 to +100
Reporting currency: USD

Who is positioning in TVGN

sample

Insiders: 32 insider transactions over 90 days, net selling, $809.2M
Congress: 5 members traded over 90 days
Institutions · 13F: 35 funds hold $14.5B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$34.0B +10.4% y/y

Q4 2024Q3 2026

Inventory$20.1B +8.3% y/y

Q4 2024Q3 2026

Accounts receivable$14.9B +3.7% y/y

Q4 2024Q3 2026

Total debt$40.0B +7.8% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $545.5B +5.0% 3M
Sample peer B: $772.9B +9.8% 3M
Sample peer C: $712.4B +15.4% 3M
Sample peer D: $442.1B -11.9% 3M
Sample peer E: $521.9B +2.3% 3M